What is the appropriate dosing frequency for meropenem in a patient with normal renal function and a serious gram‑negative infection?

Meropenem Dosing Frequency in Normal Renal Function

For adults with normal renal function and serious gram-negative infections, administer meropenem 1 gram every 8 hours by intravenous infusion over 15-30 minutes. 1

Standard Dosing Based on FDA-Approved Labeling

The FDA-approved dosing for meropenem in adults with normal renal function (creatinine clearance >50 mL/min) is:

• Complicated intra-abdominal infections: 1 gram IV every 8 hours 1
• Complicated skin/skin structure infections: 500 mg IV every 8 hours 1
• When treating Pseudomonas aeruginosa: 1 gram IV every 8 hours regardless of infection site 1

For serious gram-negative infections, the 1 gram every 8 hours regimen is the appropriate choice, as it provides adequate coverage for the most challenging pathogens including Pseudomonas aeruginosa.

Infusion Duration Considerations

The standard infusion time is 15-30 minutes 1. However, prolonged or continuous infusions should be strongly considered for infections caused by bacteria with high MIC values to optimize pharmacokinetic/pharmacodynamic (PK/PD) target attainment 2.

Recent guidelines from the French Society of Pharmacology and Therapeutics recommend:

• Prolonged or continuous infusions for infections with high MIC organisms to increase the probability of achieving PK/PD targets 2
• Higher daily doses than standard in critically ill patients with preserved renal function, as augmented renal clearance and increased volume of distribution can lead to subtherapeutic levels 2

Critical Care and Augmented Renal Clearance

Common pitfall: In critically ill patients with preserved or augmented renal function, standard dosing may be insufficient. Studies demonstrate that:

• Up to 37-44% of ICU patients fail to achieve target concentrations with standard dosing 2
• Extended infusions (≥2-3 hours) significantly improve target attainment compared to standard 30-minute infusions 3, 4
• Continuous infusion maintains higher trough concentrations in both plasma and tissue 3

For critically ill patients with augmented renal clearance (CrCl >130 mL/min), doses up to 10.5 grams daily by continuous infusion may be required 5.

PK/PD Target Optimization

The therapeutic goal is maintaining free drug concentrations above the MIC for 40-100% of the dosing interval (ƒT>MIC), depending on severity:

• Standard infections: 40% ƒT>MIC is adequate 6, 7
• Severe/bloodstream infections: 100% ƒT>MIC is preferred 4, 7
• Optimal trough concentration: ≥5.3 mg/L for general efficacy, ≥7.3 mg/L for bloodstream infections 4

Practical Algorithm

1. Start with 1 gram IV every 8 hours for serious gram-negative infections in normal renal function 1

2. Consider extended infusion (3 hours) or continuous infusion if:

   • Patient is critically ill
   • Suspected or confirmed Pseudomonas aeruginosa or Acinetobacter species
   • MIC ≥4 mg/L 2, 3, 7

3. Monitor for augmented renal clearance in critically ill patients—may require dose escalation to 2 grams every 8 hours or continuous infusion regimens 2, 5

4. Avoid neurotoxicity: Keep trough concentrations <64 mg/L to minimize seizure risk, particularly in patients with renal impairment or CNS pathology 2

The every 8-hour frequency is critical—do not extend to every 12 hours in normal renal function, as this significantly reduces target attainment against resistant organisms 6, 8.